Earnings Outlook For INmune Bio
Portfolio Pulse from Benzinga Insights
INmune Bio (NASDAQ:INMB) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.40. The company's past performance shows a pattern of EPS misses followed by share price increases. Shares are currently trading at $8.62, down 15.35% over the last 52-week period.
August 04, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
INmune Bio is expected to report an EPS of $-0.40. Despite past EPS misses, the company's share price has often increased. However, the stock is down 15.35% over the last 52 weeks.
The company's earnings report is a key event that could impact its stock price. Despite past EPS misses, the share price has often increased, suggesting that investors may be focusing more on other aspects of the company's performance. However, the stock's negative return over the past year indicates a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100